Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | CPT1A | P50416 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5630184 | 1.00 | GRM5 (0.46) | GRM5MAPK1CPT2CPT1A | |
| SCHEMBL4377245 | 0.97 | GRM5 (0.45) | GRM5MAPK1CPT2CPT1A | |
| SCHEMBL8230979 | 0.90 | GRM5 (0.36) | GRM5CPT2CPT1A | |
| SCHEMBL2894562 | 0.88 | GRM5 (0.44) | GRM5MAPK1 | |
| SCHEMBL2894551 | 0.88 | GRM5 (0.44) | GRM5MAPK1 | |
| SCHEMBL5482941 | 0.88 | GRM5 (0.45) | GRM5MAPK1CPT2CPT1A | |
| SCHEMBL5463045 | 0.88 | GRM5 (0.45) | GRM5MAPK1CPT2CPT1A | |
| SCHEMBL5463053 | 0.88 | GRM5 (0.45) | GRM5MAPK1CPT2CPT1A | |
| SCHEMBL5628529 | 0.88 | GRM5 (0.43) | GRM5CPT2CPT1A | |
| SCHEMBL5633655 | 0.88 | GRM5 (0.41) | GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259926-A1 | mGluR5 modulators III | ASTRAZENECA AB (SE) | 2007-11-08 | — | — | US | claimed |
| US-20070259926-A1 | mGluR5 modulators III | ASTRAZENECA AB (SE) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259926-A1 | mGluR5 modulators III | GRM5, GRM3, GRIK5 | GRM5 1/4885MAPK1 2236/4885CPT2 1267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.